A multilateral effort to develop DNA vaccines against falciparum malaria (Q34537728)

2 August 2017

1 reference

title

A multilateral effort to develop DNA vaccines against falciparum malaria (English)

1 reference

CVD 909 Vi Prime Boost Study

2 August 2017

0 references

Plasmodium falciparum

0 references

malaria vaccine

0 references

DNA vaccine

0 references

0 references

0 references

7

Stephen L Hoffman

1 reference

2 August 2017

Sanjai Kumar

1

1 reference

2 August 2017

Judith E Epstein

2

1 reference

2 August 2017

Thomas L Richie

3

1 reference

2 August 2017

Francis K Nkrumah

4

1 reference

2 August 2017

Lorraine Soisson

5

1 reference

2 August 2017

Daniel J Carucci

6

1 reference

2 August 2017

Kumar, S.

0 references

Epstein, J.E.

0 references

Richie, T.L.

0 references

Nkrumah, F.K.

0 references

Soisson, L.

0 references

Carucci, D.J.

0 references

Hoffman, S.L.

0 references

publication date

1 March 2002

1 reference

2 August 2017

2002

0 references

published in

Trends in Parasitology

1 reference

2 August 2017

volume

18

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

129-135

1 reference

Transmission-blocking vaccines: uses and current status of development

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Gamma-globulin and acquired immunity to human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Host age as a determinant of naturally acquired immunity to Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Immunity to non-cerebral severe malaria is acquired after one or two infections

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Malaria DNA vaccines in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Codon usage in bacteria: correlation with gene expressivity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

An evolutionary perspective on synonymous codon usage in unicellular organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902207-3

7 January 2021

10.1016/S1471-4922(01)02207-3

Identifiers

DOI

1 reference

2 August 2017

1 reference